Cargando…

A Critical Role for p53 during the HPV16 Life Cycle

Human papillomaviruses (HPV) are causative agents in ano-genital and oral cancers; HPV16 is the most prevalent type detected in human cancers. The HPV16 E6 protein targets p53 for proteasomal degradation to facilitate proliferation of the HPV16 infected cell. However, in HPV16 immortalized cells E6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fontan, Christian T., James, Claire D., Prabhakar, Apurva T., Bristol, Molly L., Otoa, Raymonde, Wang, Xu, Karimi, Elmira, Rajagopalan, Pavithra, Basu, Devraj, Morgan, Iain M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241828/ https://www.ncbi.nlm.nih.gov/pubmed/35608342 http://dx.doi.org/10.1128/spectrum.00681-22

Ejemplares similares

Human Papillomavirus 16 E6 and E7 Synergistically Repress Innate Immune Gene Transcription
por: James, Claire D., et al.
Publicado: (2020)

Human Papillomavirus 16 E2 Interaction with TopBP1 Is Required for E2 and Viral Genome Stability during the Viral Life Cycle
por: Prabhakar, Apurva T., et al.
Publicado: (2023)

Interaction with TopBP1 Is Required for Human Papillomavirus 16 E2 Plasmid Segregation/Retention Function during Mitosis
por: Prabhakar, Apurva T., et al.
Publicado: (2022)

SAMHD1 Regulates Human Papillomavirus 16-Induced Cell Proliferation and Viral Replication during Differentiation of Keratinocytes
por: James, Claire D., et al.
Publicado: (2019)

Direct interaction with the BRD4 carboxyl-terminal motif (CTM) and TopBP1 is required for human papillomavirus 16 E2 association with mitotic chromatin and plasmid segregation function
por: Prabhakar, Apurva T., et al.
Publicado: (2023)

CK2 Phosphorylation of Human Papillomavirus 16 E2 on Serine 23 Promotes Interaction with TopBP1 and Is Critical for E2 Interaction with Mitotic Chromatin and the Viral Life Cycle
por: Prabhakar, Apurva T., et al.
Publicado: (2021)

Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes
por: Fontan, Christian T., et al.
Publicado: (2020)

Werner Syndrome Protein (WRN) Regulates Cell Proliferation and the Human Papillomavirus 16 Life Cycle during Epithelial Differentiation
por: James, Claire D., et al.
Publicado: (2020)

An oral keratinocyte life cycle model identifies novel host genome regulation by human papillomavirus 16 relevant to HPV positive head and neck cancer
por: Evans, Michael R., et al.
Publicado: (2017)

Correction: An oral keratinocyte life cycle model identifies novel host genome regulation by human papillomavirus 16 relevant to HPV positive head and neck cancer
por: Evans, Michael R., et al.
Publicado: (2019)

Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells
por: Bristol, Molly L., et al.
Publicado: (2020)

HPV E6 regulates therapy responses in oropharyngeal cancer by repressing the PGC-1α/ERRα axis
por: Sannigrahi, Malay K., et al.
Publicado: (2022)

Werner Helicase Control of Human Papillomavirus 16 E1-E2 DNA Replication Is Regulated by SIRT1 Deacetylation
por: Das, Dipon, et al.
Publicado: (2019)

The Relationship between Estrogen-Related Signaling and Human Papillomavirus Positive Cancers
por: James, Claire D., et al.
Publicado: (2020)

Lysosomal inhibition sensitizes TMEM16A-expressing cancer cells to chemotherapy
por: Vyas, Avani, et al.
Publicado: (2022)

Correction for Morgan et al., “Werner Helicase Control of Human Papillomavirus 16 E1-E2 DNA Replication Is Regulated by SIRT1 Deacetylation”
por: Das, Dipon, et al.
Publicado: (2019)

DNA Damage Reduces the Quality, but Not the Quantity of Human Papillomavirus 16 E1 and E2 DNA Replication
por: Bristol, Molly L., et al.
Publicado: (2016)

Activating the DNA Damage Response and Suppressing Innate Immunity: Human Papillomaviruses Walk the Line
por: James, Claire D., et al.
Publicado: (2020)

Why Human Papillomaviruses Activate the DNA Damage Response (DDR) and How Cellular and Viral Replication Persists in the Presence of DDR Signaling
por: Bristol, Molly L., et al.
Publicado: (2017)

Using a Human Papillomavirus Model to Study DNA Replication and Repair of Wild Type and Damaged DNA Templates in Mammalian Cells
por: Das, Dipon, et al.
Publicado: (2020)

HPV infection and p53 and p16 expression in esophageal cancer: are they prognostic factors?
por: da Costa, Allini Mafra, et al.
Publicado: (2017)

Brucella abortus RB51 lipopolysaccharide influence as an adjuvant on the therapeutic efficacy of HPV16 L1 and HPV16 E7 DNA vaccines
por: Shirmohammadi, Masoumeh, et al.
Publicado: (2021)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

Formal modeling and analysis of timed systems: 16th international conference, FORMATS 2018, Beijing, China, September 4-6, 2018, proceedings
por: Jansen, David N, et al.
Publicado: (2018)

The Relation of HPV Infection and Expression of p53 and p16 Proteins in Esophageal Squamous Cells Carcinoma
por: Pastrez, Paula Roberta Aguiar, et al.
Publicado: (2017)

p53 Is Regulated in a Biphasic Manner in Hypoxic Human Papillomavirus Type 16 (HPV16)-Positive Cervical Cancer Cells
por: Zhuang, Linhan, et al.
Publicado: (2020)

E6/E7 and E6(*) From HPV16 and HPV18 Upregulate IL-6 Expression Independently of p53 in Keratinocytes
por: Artaza-Irigaray, Cristina, et al.
Publicado: (2019)

Anti-HPV16 Antibody Titers Prior to an Incident Cervical HPV16/31 Infection
por: Gradissimo, Ana, et al.
Publicado: (2021)

HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial
por: Tsang, Sabrina H., et al.
Publicado: (2022)

Prevalence of HPV 16 and HPV 18 Lineages in Galicia, Spain
por: Pérez, Sonia, et al.
Publicado: (2014)

Interaction of HPV16 and Cutaneous HPV in Head and Neck Cancer
por: Al-Soneidar, Walid A., et al.
Publicado: (2022)

Association of Combined p73 and p53 Genetic Variants with Tumor HPV16-Positive Oropharyngeal Cancer
por: Wang, Zhongqiu, et al.
Publicado: (2012)

Does HPV 16/18 infection affect p53 expression in invasive ductal carcinoma? An experimental study
por: Hong, Liang, et al.
Publicado: (2014)

Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma
por: Xie, Xiujie, et al.
Publicado: (2013)

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
por: van Poelgeest, Mariette I E, et al.
Publicado: (2013)

The Expression Patterns of p53 and p16 and an Analysis of a Possible Role of HPV in Primary Adenocarcinoma of the Urinary Bladder
por: Alexander, Riley E., et al.
Publicado: (2014)

p53 represses human papillomavirus type 16 DNA replication via the viral E2 protein
por: Brown, Craig, et al.
Publicado: (2008)

p16 in HPV-associated cancers
por: Munger, Karl, et al.
Publicado: (2013)

HPV infection and p53 inactivation in pterygium
por: Tsai, Yi-Yu, et al.
Publicado: (2009)

Dynamic response of HPV16/anti-HPV16 pairs with unbinding events studied by atomic force microscopy
por: Lin, Shiming, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_81m2lcbbjemlmsnrsanadab6bh